BD bone marrow aspiration
Taiwan·Risk Class 2·BARD PERIPHERAL VASCULAR, INC.;; CAREFUSION D.R. 203, LTD.·Registered Dec 08, 2016 – Dec 08, 2021Cancelled- Analysis ID
- 0cec55aad514770666b77a2aa9181cce
- Customs Code
- DHA05602920706
- Manufacturer Country
- Dominican Republic;;United States
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- H Gastroenterology and urology
- Product Type (Level 2)
- H.1075 腸胃科-泌尿科生檢器械
- Import Information
- Contract manufacturing;; input
- Registration Date
- Dec 08, 2016
- Expiry Date
- Dec 08, 2021
- Cancellation Date
- Sep 08, 2023
- Status
- Logged out
- Reason
- 未展延而逾期者
Top companies providing products similar to "BD bone marrow aspiration"
Recently registered similar products
Access comprehensive regulatory information for BD bone marrow aspiration in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 0cec55aad514770666b77a2aa9181cce and manufactured by BARD PERIPHERAL VASCULAR, INC.;; CAREFUSION D.R. 203, LTD.. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including BARD PERIPHERAL VASCULAR, INC.;; CAREFUSION 2200, INC., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.